Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 …
Background: We assessed the effect of once-weekly semaglutide and once-daily liraglutide
on kidney outcomes in type 2 diabetes. Methods: Pooled (n= 12 637) and by-trial data from …
on kidney outcomes in type 2 diabetes. Methods: Pooled (n= 12 637) and by-trial data from …
Effect of the Glucagon-like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of …
AM Shaman, SC Bain, GL Bakris, JB Buse, T Idorn… - …, 2022 - research.regionh.dk
BACKGROUND: We assessed the effect of once-weekly semaglutide and once-daily
liraglutide on kidney outcomes in type 2 diabetes. METHODS: Pooled (n= 12 637) and by …
liraglutide on kidney outcomes in type 2 diabetes. METHODS: Pooled (n= 12 637) and by …
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of …
AM Shaman, SC Bain, GL Bakris, JB Buse, T Idorn… - Circulation, 2022 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> We assessed the effect of once-
weekly semaglutide and once-daily liraglutide on kidney outcomes in type 2 diabetes.</jats …
weekly semaglutide and once-daily liraglutide on kidney outcomes in type 2 diabetes.</jats …
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of …
AM Shaman, SC Bain, GL Bakris, JB Buse, T Idorn… - 2022 - pubmed.ncbi.nlm.nih.gov
Background We assessed the effect of once-weekly semaglutide and once-daily liraglutide
on kidney outcomes in type 2 diabetes. Methods Pooled (n= 12 637) and by-trial data from …
on kidney outcomes in type 2 diabetes. Methods Pooled (n= 12 637) and by-trial data from …
[HTML][HTML] Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis …
AM Shaman, SC Bain, GL Bakris, JB Buse, T Idorn… - Circulation, 2022 - ncbi.nlm.nih.gov
BACKGROUND: We assessed the effect of once-weekly semaglutide and once-daily
liraglutide on kidney outcomes in type 2 diabetes. METHODS: Pooled (n= 12 637) and by …
liraglutide on kidney outcomes in type 2 diabetes. METHODS: Pooled (n= 12 637) and by …
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of …
AM Shaman, SC Bain, GL Bakris, JB Buse, T Idorn… - Circulation, 2022 - cdr.lib.unc.edu
Background: We assessed the effect of once-weekly semaglutide and once-daily liraglutide
on kidney outcomes in type 2 diabetes. Methods: Pooled (n= 12 637) and by-trial data from …
on kidney outcomes in type 2 diabetes. Methods: Pooled (n= 12 637) and by-trial data from …
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of …
AM Shaman, SC Bain, GL Bakris, JB Buse, T Idorn… - Circulation, 2021 - europepmc.org
Background We assessed the effect of once-weekly semaglutide and once-daily liraglutide
on kidney outcomes in type 2 diabetes. Methods Pooled (n= 12 637) and by-trial data from …
on kidney outcomes in type 2 diabetes. Methods Pooled (n= 12 637) and by-trial data from …
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of …
AM Shaman, SC Bain, GL Bakris, JB Buse, T Idorn… - 2022 - pubmed.ncbi.nlm.nih.gov
Background We assessed the effect of once-weekly semaglutide and once-daily liraglutide
on kidney outcomes in type 2 diabetes. Methods Pooled (n= 12 637) and by-trial data from …
on kidney outcomes in type 2 diabetes. Methods Pooled (n= 12 637) and by-trial data from …